Featured Research

from universities, journals, and other organizations

Antibacterial protein's molecular workings revealed

Date:
February 21, 2013
Source:
Vanderbilt University Medical Center
Summary:
Investigators report new insights to the workings of calprotectin, an immune system protein that "starves" bacterial pathogens of the metal nutrients they require. The findings, which include a detailed structural view of how calprotectin binds the metal manganese, could guide efforts to develop novel antibacterials that limit a microbe's access to metals.

On the front lines of our defenses against bacteria is the protein calprotectin, which "starves" invading pathogens of metal nutrients.

Vanderbilt investigators now report new insights to the workings of calprotectin -- including a detailed structural view of how it binds the metal manganese. Their findings, published online before print in the Proceedings of the National Academy of Sciences, could guide efforts to develop novel antibacterials that limit a microbe's access to metals.

The increasing resistance of bacteria to existing antibiotics poses a severe threat to public health, and new therapeutic strategies to fight these pathogens are needed. The idea of "starving" bacteria of metal nutrients is appealing, said Eric Skaar, Ph.D., MPH, associate professor of Pathology, Microbiology and Immunology.

In a series of previous studies, Skaar, Walter Chazin, Ph.D., and Richard Caprioli, Ph.D., demonstrated that calprotectin is highly expressed by host immune cells at sites of infection. They showed that calprotectin inhibits bacterial growth by "mopping up" the manganese and zinc that bacteria need for replication.

Now, the researchers have identified the structural features of calprotectin's two metal binding sites and demonstrated that manganese binding is key to its antibacterial action.

Calprotectin is a member of the family of S100 calcium-binding proteins, which Chazin, professor of Biochemistry and Chemistry, has studied for many years. Chazin and postdoctoral fellow Steven Damo, Ph.D., used existing structural data from other S100 family members to zero in on calprotectin's two metal binding sites. Then, they selectively mutated one site or the other.

They discovered that calprotectin with mutations in one of the two sites still bound both zinc and manganese, but calprotectin with mutations in the other site only bound zinc.

The researchers recognized that these modified calprotectins -- especially the one that could no longer bind manganese -- would be useful tools for determining the importance of manganese binding to calprotectin's functions, Chazin noted.

Thomas Kehl-Fie, Ph.D., a postdoctoral fellow in Skaar's group, used these altered calprotectins to demonstrate that the protein's ability to bind manganese is required for full inhibition of Staphylococcus aureus growth. The investigators also showed that Staph bacteria require manganese for a certain process the bacteria use to protect themselves from reactive oxygen species.

"These altered calprotectin proteins were key to being able to tease apart the importance of the individual metals -- zinc and manganese -- to the bacterium as a whole and to metal-dependent processes within the bacteria," Skaar said. "They're really powerful tools."

Skaar explained that calprotectin likely binds two different metals to increase the range of bacteria that it inhibits. The investigators tested the modified calprotectins against a panel of medically important bacterial pathogens.

"Bacteria have different metal needs," Skaar said. "Some bacteria are more sensitive to the zinc-binding properties of calprotectin, and others are more sensitive to the manganese-binding properties."

To fully understand how calprotectin binds manganese, Damo and Chazin -- with assistance from Gόnter Fritz, Ph.D., at the University of Freiburg in Germany -- produced calprotectin crystals with manganese bound and determined the protein structure. They found that manganese slips into a position where it interacts with six histidine amino acids of calprotectin.

It's really beautiful; no one's ever seen a protein chelate (bind) manganese like this," Chazin said."It's really beautiful; no one's ever seen a protein chelate (bind) manganese like this," Chazin said.

The structure explains why calprotectin is the only S100 family member that binds manganese and has the strongest antimicrobial action, and it may allow researchers to design a calprotectin that only binds manganese (not zinc). Such a tool would be useful for studying why bacteria require manganese -- and then targeting those microbial processes in new therapeutic strategies, Chazin and Skaar noted.

"We do not know all of the processes within Staph that require manganese; we just know if they don't have it, they die," Skaar said. "If we can discover the proteins in Staph that require manganese -- the things that are required for growth -- then we can target those proteins."

The team recently was awarded a five-year, $2 million grant from the National Institute of Allergy and Infectious Diseases (AI101171) to advance their studies of calprotectin and how it works to limit bacterial infections and in other inflammatory conditions.

"Nature stumbled onto an interesting antimicrobial strategy," Chazin said. "Our goal is to really tease apart the importance of metal binding to all of calprotectin's different roles -- and to take advantage of our findings to design new antibacterial agents."

The research was supported by grants from the National Institutes of Health (CA009582, HL094296, AI091771, AI069233, AI073843, GM062122). Skaar holds the Ernest W. Goodpasture Chair in Pathology; Chazin holds the Chancellor's Chair in Biochemistry and Chemistry and is director of the Vanderbilt Center for Structural Biology.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. The original article was written by Leigh MacMillan. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. M. Damo, T. E. Kehl-Fie, N. Sugitani, M. E. Holt, S. Rathi, W. J. Murphy, Y. Zhang, C. Betz, L. Hench, G. Fritz, E. P. Skaar, W. J. Chazin. Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1220341110

Cite This Page:

Vanderbilt University Medical Center. "Antibacterial protein's molecular workings revealed." ScienceDaily. ScienceDaily, 21 February 2013. <www.sciencedaily.com/releases/2013/02/130221115918.htm>.
Vanderbilt University Medical Center. (2013, February 21). Antibacterial protein's molecular workings revealed. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2013/02/130221115918.htm
Vanderbilt University Medical Center. "Antibacterial protein's molecular workings revealed." ScienceDaily. www.sciencedaily.com/releases/2013/02/130221115918.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins